Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
ECX, ONON, LODE, More
Revenue Growth %: -5.7%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6.93 million versus the consensus estimate of $4.77 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades On Holding AG (ONON) to Market Perform
- ACCESS Newswire Inc. (ACCS) Misses Q2 EPS by 17c
- Capital One credit card shift to Discover seen limited
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
